fibrinolysins

researchers are investigating the potential of fibrinolysins for treating ischemic stroke.

fibrinolysins can effectively dissolve blood clots in the circulatory system.

the development of novel fibrinolysins is a key area of pharmaceutical research.

administering fibrinolysins requires careful monitoring of patient coagulation status.

engineered fibrinolysins offer improved efficacy and reduced bleeding risks.

fibrinolysins' mechanism of action involves the breakdown of fibrin networks.

clinical trials are evaluating the safety and efficacy of recombinant fibrinolysins.

the rapid onset of action is a significant advantage of certain fibrinolysins.

understanding fibrinolysins' interactions with other clotting factors is crucial.

fibrinolysins are being explored as a potential treatment for deep vein thrombosis.

the stability of fibrinolysins in storage is an important consideration for manufacturers.